Literature DB >> 3000602

Hierarchical down-modulation of hemopoietic growth factor receptors.

F Walker, N A Nicola, D Metcalf, A W Burgess.   

Abstract

Granulocytes and macrophages can be produced in vitro when progenitor cells from mouse bone marrow are stimulated by any of four distinct colony stimulating factors, Multi-CSF (IL-3), GM-CSF, G-CSF, and M-CSF (CSF-1). At 0 degrees C the four CSFs do not cross-compete for binding to bone marrow cells, indicating that each has a specific cell surface receptor. However, at 21 degrees C or 37 degrees C, Multi-CSF inhibits binding of the other three CSFs and GM-CSF inhibits binding of G-CSF and M-CSF. Rather than competing directly for receptor binding, the binding of Multi-CSF, GM-CSF, or G-CSF to their own receptor induces the down-modulation (and thus activation) of other CSF receptors at 37 degrees C. The pattern and potency of down-modulation activity exhibited by each type of CSF parallels the pattern and potency of its biological activity. We propose a model in which the biological interactions of the four CSFs are explained by their ability to down-modulate and activate lineage-specific receptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3000602     DOI: 10.1016/0092-8674(85)90032-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  48 in total

Review 1.  Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

Authors:  F Herrmann; R Mertelsmann
Journal:  Blut       Date:  1989-03

2.  The proliferative and morphologic responses of a colon carcinoma cell line (LIM 1215) require the production of two autocrine factors.

Authors:  A M Sizeland; A W Burgess
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

3.  Hematopoietic growth factors.

Authors:  C A Sieff
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

4.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

5.  Early T-cell progenitors are the major granulocyte precursors in the adult mouse thymus.

Authors:  Maria Elena De Obaldia; J Jeremiah Bell; Avinash Bhandoola
Journal:  Blood       Date:  2012-11-14       Impact factor: 22.113

6.  Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils.

Authors:  A F Lopez; J M Eglinton; D Gillis; L S Park; S Clark; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  Interleukin-3-stimulated haemopoietic stem cell proliferation. Evidence for activation of protein kinase C and Na+/H+ exchange without inositol lipid hydrolysis.

Authors:  A D Whetton; S J Vallance; P N Monk; E J Cragoe; T M Dexter; C M Heyworth
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

8.  A human GM-CSF receptor expressed in transgenic mice stimulates proliferation and differentiation of hemopoietic progenitors to all lineages in response to human GM-CSF.

Authors:  I Nishijima; T Nakahata; Y Hirabayashi; T Inoue; H Kurata; A Miyajima; N Hayashi; Y Iwakura; K Arai; T Yokota
Journal:  Mol Biol Cell       Date:  1995-05       Impact factor: 4.138

9.  The combined effect of erythropoietin and granulocyte macrophage colony stimulating factor on liver regeneration after major hepatectomy in rats.

Authors:  Ioannis Vassiliou; Evangelos Lolis; Constantinos Nastos; Aliki Tympa; Theodosios Theodosopoulos; Nikolaos Dafnios; George Fragulidis; Matrona Frangou; Agathi Kondi-Pafiti; Vassilios Smyrniotis
Journal:  World J Surg Oncol       Date:  2010-07-07       Impact factor: 2.754

10.  An Atypical Splenic B Cell Progenitor Population Supports Antibody Production during Plasmodium Infection in Mice.

Authors:  Debopam Ghosh; Daniel J Wikenheiser; Brian Kennedy; Kathryn E McGovern; Johnasha D Stuart; Emma H Wilson; Jason S Stumhofer
Journal:  J Immunol       Date:  2016-07-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.